Long-term protection in children with meningococcal C conjugate vaccination: Lessons learned

Keyphrases

• Age Groups 100%
• All Ages 40%
• Antibody Immunity 20%
• Antibody Persistence 40%
• Avidity Index 20%
• Confidence Interval 40%
• Conjugate Vaccine 100%
• CRM197 20%
• Disease Control 40%
• First Year 20%
• Herd Immunity 40%
• Immune Memory 60%
• Immunization Programs 20%
• Immunization Schedule 20%
• Immunogenicity 20%
• Infant Immunization 40%
• Infant Patients 20%
• Lessons Learned 100%
• Long-term Disease 20%
• Long-term Protection 100%
• Number of Groups 20%
• Polysaccharide 20%
• Post-primary 20%
• Prelicensure 20%
• Primary Immunization 20%
• Routine Immunization 20%
• Tetanus Toxoid 20%
• Toddlers 20%
• Two-dose 20%
• UK Department of Health 20%
• Vaccination 40%
• Vaccine Effectiveness 20%
• Vaccine Failure 20%
• Vaccine Manufacturers 20%
• Young children 20%

Medicine and Dentistry

• Conjugate Vaccine 66%
• Diphtheria Toxoid CRM197 33%
• Diseases 100%
• Herd Immunity 66%
• Immunogenicity 33%
• Immunological Memory 100%
• Infancy 33%
• Low Drug Dose 33%
• Polysaccharide 33%
• Single Drug Dose 33%
• Tetanus Toxoid 33%
• Vaccine Failure 33%

Immunology and Microbiology

• Conjugate Vaccine 66%
• Diphtheria Toxoid CRM197 33%
• Herd Immunity 66%
• Immunogenicity 33%
• Immunological Memory 100%
• Infancy 33%
• Low Drug Dose 33%
• Tetanus Vaccine 33%
• Vaccine Failure 33%